CI Canadian Convertible Bond ETF Common (CXF) Competitors C$10.15 -0.11 (-1.07%) (As of 12/20/2024 05:17 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlines CXF vs. FRX, APM, IPA, ITH, CRDL, MDNA, GXE, GPH, EQ, and WMDShould you be buying CI Canadian Convertible Bond ETF Common stock or one of its competitors? The main competitors of CI Canadian Convertible Bond ETF Common include Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), ImmunoPrecise Antibodies (IPA), International Tower Hill Mines (ITH), Cardiol Therapeutics (CRDL), Medicenna Therapeutics (MDNA), Gear Energy (GXE), Graphite One (GPH), EQ (EQ), and WeedMD (WMD). These companies are all part of the "pharmaceutical products" industry. CI Canadian Convertible Bond ETF Common vs. Fennec Pharmaceuticals Andean Precious Metals ImmunoPrecise Antibodies International Tower Hill Mines Cardiol Therapeutics Medicenna Therapeutics Gear Energy Graphite One EQ WeedMD Fennec Pharmaceuticals (TSE:FRX) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, community ranking, profitability, earnings and risk. Does the media prefer FRX or CXF? In the previous week, Fennec Pharmaceuticals had 5 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 5 mentions for Fennec Pharmaceuticals and 0 mentions for CI Canadian Convertible Bond ETF Common. CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 beat Fennec Pharmaceuticals' score of -0.36 indicating that CI Canadian Convertible Bond ETF Common is being referred to more favorably in the news media. Company Overall Sentiment Fennec Pharmaceuticals Neutral CI Canadian Convertible Bond ETF Common Neutral Is FRX or CXF more profitable? Fennec Pharmaceuticals has a net margin of 5.59% compared to CI Canadian Convertible Bond ETF Common's net margin of 0.00%. CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Fennec Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Fennec Pharmaceuticals5.59% -1,005.59% 8.88% CI Canadian Convertible Bond ETF Common N/A N/A N/A Do analysts prefer FRX or CXF? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fennec Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00CI Canadian Convertible Bond ETF Common 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable valuation and earnings, FRX or CXF? Fennec Pharmaceuticals has higher revenue and earnings than CI Canadian Convertible Bond ETF Common. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFennec PharmaceuticalsC$48.89M4.80C$2.73MC$0.1085.70CI Canadian Convertible Bond ETF CommonN/AN/AN/AN/AN/A Do institutionals and insiders hold more shares of FRX or CXF? 52.8% of Fennec Pharmaceuticals shares are owned by institutional investors. 16.2% of Fennec Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in FRX or CXF? Fennec Pharmaceuticals received 93 more outperform votes than CI Canadian Convertible Bond ETF Common when rated by MarketBeat users. Likewise, 69.80% of users gave Fennec Pharmaceuticals an outperform vote while only 57.89% of users gave CI Canadian Convertible Bond ETF Common an outperform vote. CompanyUnderperformOutperformFennec PharmaceuticalsOutperform Votes10469.80% Underperform Votes4530.20% CI Canadian Convertible Bond ETF CommonOutperform Votes1157.89% Underperform Votes842.11% SummaryFennec Pharmaceuticals beats CI Canadian Convertible Bond ETF Common on 10 of the 12 factors compared between the two stocks. Ad InvestorPlaceWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.This market shakeup is going to be much more intense. Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically Sign up to receive the latest news and ratings for CXF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CXF vs. The Competition Export to ExcelMetricCI Canadian Convertible Bond ETF CommonPharmaceutical Preparations IndustryManufacturing SectorTSE ExchangeMarket CapC$61.89MC$6.57BC$2.17BC$6.07BDividend Yield4.99%3.00%2.72%5.42%P/E RatioN/A10.5527.6426.16Price / SalesN/A196.06167.931,332.85Price / CashN/A57.16N/A82.30Price / BookN/A5.091.943.07Net IncomeN/AC$151.83MC$257.43MC$295.24M7 Day Performance-0.68%-2.14%-2.18%-2.48%1 Month Performance3.15%-4.56%-0.19%-0.91%1 Year Performance12.40%8.87%5.69%33.65% CI Canadian Convertible Bond ETF Common Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CXFCI Canadian Convertible Bond ETF CommonN/AC$10.15-1.1%N/A+12.4%C$61.89MN/A0.0090FRXFennec PharmaceuticalsN/AC$8.51-2.0%N/A-39.0%C$232.83MC$48.89M85.1010Analyst RevisionNews CoverageAPMAndean Precious MetalsN/AC$1.32-3.6%C$1.70+28.8%N/AC$197.16MC$199.84M3.4730IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080News CoverageGap DownITHInternational Tower Hill MinesN/AC$0.69-4.2%N/A-9.5%C$137.79MN/A-23.00220Gap DownCRDLCardiol TherapeuticsN/AC$1.91+1.1%N/A+61.2%C$133.12MN/A-4.3320News CoverageMDNAMedicenna TherapeuticsN/AC$1.72-2.8%N/A+317.1%C$131.46MN/A-4.5320GXEGear Energy2.9755 of 5 starsC$0.48flatC$1.00+108.3%-26.6%C$126.52MC$134.93M9.601,310Dividend AnnouncementGPHGraphite OneN/AC$0.71-4.1%N/A-20.7%C$98.39MN/A-10.1420EQEQN/AC$1.09+0.9%N/A+33.3%C$75.85MC$9.86M-15.5740WMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up Related Companies and Tools Related Companies FRX Alternatives APM Alternatives IPA Alternatives ITH Alternatives CRDL Alternatives MDNA Alternatives GXE Alternatives GPH Alternatives EQ Alternatives WMD Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:CXF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CI Canadian Convertible Bond ETF Common Please log in to your account or sign up in order to add this asset to your watchlist. Share CI Canadian Convertible Bond ETF Common With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CXF Stock Alerts